# Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis

> **NCT02568293** · NA · UNKNOWN · sponsor: **Symic Vascular** · enrollment: 66 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **OTHER:** SBCV
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT02568293
- **Lead sponsor:** Symic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2017-09
- **Final completion:** 2017-10
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2017-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02568293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02568293, "Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02568293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
